-
1 Comment
Evogene Ltd is currently in a long term downtrend where the price is trading 31.2% below its 200 day moving average.
From a valuation standpoint, the stock is 89.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 135.9.
Evogene Ltd's total revenue rose by 202.6% to $351K since the same quarter in the previous year.
Its net income has dropped by 33.6% to $-8M since the same quarter in the previous year.
Finally, its free cash flow fell by 33.1% to $-7M since the same quarter in the previous year.
Based on the above factors, Evogene Ltd gets an overall score of 2/5.
ISIN | IL0011050551 |
---|---|
Sector | Healthcare |
Industry | Biotechnology |
Exchange | NASDAQ |
CurrencyCode | USD |
Beta | 1.18 |
---|---|
Market Cap | 8M |
PE Ratio | None |
Target Price | 5.5 |
Dividend Yield | None |
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EVGN using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025